Over recent years, there has been an increasing number of biologic medications used for IBD treatment, such as monoclonal antibodies or inhibitors to tumor necrosis factor (TNF)-α, interleukin (IL)-12/23, adhesion molecules, and Janus kinase (JAK). Here, TNF is linked to inflammatory bowel disease.